trending Market Intelligence /marketintelligence/en/news-insights/trending/-ilQ6yqMLDlCieIV4JKhnw2 content esgSubNav
Log in to other products


Looking for more?

Contact Us
In This List

Cerecor starts at-the-market equity offering program


COVID-19 Impact & Recovery: Healthcare Outlook for H2 2021


Climate Credit Analytics: Linking climate scenarios to financial impacts


Global M&A Infographic Q1 2021


Q1 2021 Global Capital Markets Activity: SPAC IPOs, Issuance in Consumer Discretionary Sector Surge

Cerecor starts at-the-market equity offering program

Cerecor Inc. agreed to sell, from time to time, its common stock with a gross sales price of up to $12.1 million in an at-the-market equity offering program.

The company plans to use net proceeds from the offering to partially fund its research and development of its receptor antagonists CERC-501 and CERC-611 in its pipeline, pursue potential partnerships, collaborations or out-licenses, and for general working capital.

Maxim Group LLC is the sales agent for the offering.